From: Increasing protocol suitability for clinical trials in sub-Saharan Africa: a mixed methods study
 |  | Ghana | Burkina Faso | Senegal |
---|---|---|---|---|
(n = 8) | (n = 16) | (n = 12) | ||
Role in trial | Investigators | 2 | 8 | 6 |
(n = 16) | ||||
Study coordinators | 4 | 3 | 3 | |
(n = 10) | ||||
Clinicians | 1 | 3 | 2 | |
(n = 6) | ||||
QA professionals | 1 | 2 | 1 | |
(n = 4) | ||||
Clinical research experience | 0 to 1Â year | 0 | 1 | 1 |
2 to 4Â years | 2 | 5 | 2 | |
5 to 7Â years | 1 | 0 | 1 | |
More than 7Â years | 5 | 10 | 8 | |
Study Phase | Phase I (a or b) | 2 | 10 | 2 |
Phase II | 2 | 13 | 3 | |
Phase III | 6 | 13 | 6 | |
Phase IV | 5 | 9 | 3 | |
Type of trial | Drug trial | 4 | 16 | 9 |
Vaccine trial | 7 | 13 | 7 |